Daily Journal Staff Writer
WASHINGTON - In an intellectual property dispute pitting Stanford University against a multinational biotech firm, the U.S. Supreme Court considered Monday who owns patent rights for inventions arising from federally funded research projects.
Stanford claims Roche Molecular Systems Inc. infringed its patents for a process testing how well anti-AIDS drugs work, but the U.S. Court of Appeals for the F...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In